Sonablate

USACharlotteBiotech & PharmaUndisclosed

Overview

Where Sonablate is now

Sonablate announced a funding round of $200M on 10 August 2026.

Observed Described in the funding announcement as "provider of AI-powered precision medicine and intelligent, image-guided therapeutic ultrasound technologies". Source

Latest round
Undisclosed
Amount
$200M
Announced
10 August 2026
Headquarters
Charlotte, USA
Sector
Biotech & Pharma
Growth stage
Growth
Investors
Not stated
Also participating
Not stated
Relevant leadership
CEO Richard Yang

Current direction Inferred

What this company is working on

Commercial growthManufacturing and scale

Read from the company's own description of what the funding supports.

Momentum Inferred

AfterRaise Score

72
Building momentum
1 funding signal in the last 90 days
Funding recency
40/40
announced within the last 30 days
Round scale
22/25
round size relative to the market
Funding stage
10/20
Undisclosed
Funding cadence
0/15
one funding event tracked this year
Arriving with the signals layer
  • Hiring momentum Open roles and hiring pace
  • Market expansion New offices and new countries
  • Leadership Executive appointments
  • Product activity Launches and releases

Growth timeline

What has happened so far

  • 10 August 2026
    $200M raised
    Investors not stated in the announcement.

Observed The timeline currently holds funding events, because those are the signals AfterRaise observes today. Hiring, leadership, expansion and product events join it with the signals layer.

Moves

Published by the company

Share a Move

No company-published Moves yet

AfterRaise has the funding facts for Sonablate from public sources. What it does not have is what the company is doing next, in the company's own words. That part only they can write.

Work here? Publish the first Move

Opportunities

Work this company has opened

No open Opportunities listed

Jobs, projects, partnerships and advisory needs appear here once the company has claimed its room and published them.

Work here? Open the first one

Open to

Who may approach Sonablate

Not yet specified

Sonablate has not told AfterRaise which approaches it welcomes. Until it does, we do not assume. Offers to help are held and shown to the company, and the company decides whether to open a conversation.

Work here? Set your preferences

Helpful contributors

People who have contributed here

Nobody yet

When someone offers help and the company says it was useful, they appear here. Reputation on AfterRaise is built from contributions the company confirmed, not from follower counts.

Work here?

This room belongs to Sonablate.

Claim it to publish Moves in your own words, open Opportunities, choose who may approach you, and see the offers of help you have received. Everything you publish is reviewed before it appears.

Also moving

Other Biotech & Pharma companies

See the sector